Experience

A decade of process development, increasingly through models.

  1. 2025 — Present

    Director

    Merck & Co., Inc. · DSCS Digital — Process Modeling & Analytics

    Leads the Process Modeling & Analytics function within Digital Sciences, Commercialization & Supply.

  2. 2023 — 2025

    Principal Scientist

    Merck & Co., Inc. · PR&D Data-Rich Experimentation

    • Team leadership: Led a diverse team delivering new technology and expert support to a complex pipeline, driving meaningful coaching and employee development to maximize personal, career, and business fulfillment. Coached a larger group of scientists across the organization as the Data-Rich Experimentation (DRE) scientific lead and leadership-team member.
    • AI for pharma: Championed the development and deployment of transformative digital capabilities, including algorithmic process optimization and Neural ODE hybrid models. Grew uptake of AI tools to ~100 end users across PR&D and 10+ pipeline programs in under two years, realizing substantial gains in experiment reduction alongside enhanced process quality and productivity.
    • Digital transformation: Led five cross-divisional technical teams, including a network of IT stakeholders, to pioneer a modern, digitally enabled research organization. Delivered three accelerated use cases and continues to mature additional in-silico platforms spanning cell-culture and chromatography modeling, systems biology and omics, solubility and morphology prediction, and protein engineering.
  3. 2019 — 2023

    Senior Scientist — Associate Principal Scientist

    Merck & Co., Inc. · PR&D Data-Rich Experimentation

    • Data science: Drove impactful process-optimization and development decisions from laboratory data across multiple modalities using mechanistic and machine-learning analyses. Regularly upskilled the department as a subject-matter expert. Developed and deployed enabling tools to solve pipeline challenges (enzyme-cascade analyses, Monte Carlo control strategy, dynamic RSM, nitrosamine kinetic models, end-user Bayesian optimization, and more).
    • High-throughput experimentation: Developed and deployed new automation, intensification, and parallelization technologies for efficient process development. Delivered key milestones for route scouting, process development, characterization, piloting, and tech transfer across a wide variety of small-molecule assets using data-rich techniques.
    • External science: Represented Merck's strategic interests while advancing the field through academic collaborations and pre-competitive industry consortia. Served as DRE team lead for new-collaboration proposal review and development, and individually contributed to multiple external engagements leading to frequent co-authored publications.
  4. 2015 — 2019

    Associate Scientist — Scientist

    Merck & Co., Inc. · Chemical Engineering Research & Development

    • Reaction engineering: Consulted on particularly challenging chemical syntheses — flow chemistry, photochemistry, electrochemistry, and biocatalysis — through lab and modeling work. Served as lead engineer for the first kilogram-scale electrochemistry demonstrations, overseeing equipment design and scale-up strategy.
    • Commercialization: Technical lead for PPQ process validation, including tech transfer to an international supply site. Leveraged modern data-rich experimentation and process analytical technology to enrich late-stage development, and authored related sections for the NDA filing. Completed a rotation as a process engineer in the small-molecule pilot plant.

Honors & awards

  • 2025

    Data Science & Modeling for Green Chemistry

    ACS GCI Pharmaceutical Roundtable

  • 2024

    Technical Achievements in Organic Chemistry

    ACS Division of Organic Chemistry

  • 2022

    Outstanding Publication of the Year

    Organic Process Research & Development

  • 2018, 2021, 2022

    ACS & EPA Green Chemistry Awards

    ACS & U.S. EPA

    Sustainable synthetic pathways for doravirine, gefapixant, and molnupiravir (separately).

  • 2021

    Merck MS&T Innovation Award

    Merck & Co., Inc.

    In-silico analysis of nitrosamine formation in commercial products.

  • 2015, 2016

    Merck CERD Technical Achievement Awards

    Merck & Co., Inc.

    Individual contributions to commercial process development.

Invited talks & presentations

  • Keynote

    Predictive Models for Pharmaceutical Development: Scaling Mechanistic, Hybrid, and Data-Driven Approaches

    Industrial Applications in Computing and Systems Technology (CAST), 2026

  • Invited talk

    Accelerating and Optimizing mAb Production with Hybrid Models: GARNET Bioreactor Digital Twin

    Recovery Series — 6th Modeling Workshop, 2025

  • Invited talk

    Algorithmic Process Optimization for Pharmaceutical Development

    Kinetic Modeling Roundtable 2025: AI & ML · ACS Green Chemistry & Engineering (GC&E), 2025 · Active Learning Symposium, 2024

  • Webinar

    Practical Application of Mechanism & Kinetics in the Development Pipeline

    Mettler Toledo Webinar, 2023

  • Webinar

    Development of a Transfer Hydrogenation Controlled by Nitrogen Flow en Route to Belzutifan

    Mettler Toledo Webinar, 2022

  • Webinar

    Reaction Kinetic Modeling and Process Optimization of a Multi-Enzyme Biocatalytic Synthesis

    Scale-Up Systems Webinar, 2020

  • Webinar

    Process Fingerprinting Tools in the Development of an Alkylation Reaction

    Mettler Toledo Webinar, 2019

Industry leadership & service

  • 2026

    Programming Chair & Executive Committee Member

    AIChE Pharmaceutical Discovery, Development, and Manufacturing (PD2M) Forum

  • 2026

    Session Chair

    AIChE Student Conference — Chemical Engineering in the Pharmaceutical Industry

  • 2024, 2025

    Track Chair — Predictive Scale-Up / Scale-Down

    AIChE Pharmaceutical Discovery, Development, and Manufacturing (PD2M) Forum

  • 2024

    Session Chair — Continuous Processing in Drug Substance & Drug Product

    AIChE Pharmaceutical Discovery, Development, and Manufacturing (PD2M) Forum

  • 2024

    Scientific Advisory Board Member

    Technobis ReactALL Development Program

  • 2021, 2022, 2023, 2024, 2025

    Steering Committee Member

    Mettler Toledo Kinetic Modeling Roundtable